Exploring the effects of postbiotics on elderly hemodialysis patients
Official title: A Postbiotics Improves the Quality of Life and Nutritional Status in Elderly Hemodialysis Patients
Run by Peking University First Hospital · NCT06975995 · Data updated 2026-11-12
This study is testing if a new postbiotics product can improve the quality of life and nutrition for elderly patients on hemodialysis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Peking University First Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | August 1, 2024 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | May 16, 2025 |
| Trial ID | NCT06975995 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are elderly individuals aged 65 and older who have been on maintenance hemodialysis for at least six months.
✕Probably not a fit
Patients with recent gastrointestinal issues or conditions affecting oral feeding may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial investigates the impact of exogenous postbiotics on the quality of life and nutritional status of elderly patients undergoing hemodialysis. Participants aged 65 and older will be randomly assigned to receive either a postbiotics product or a placebo for 12 weeks, followed by a crossover period where the placebo group will receive the postbiotics. The study aims to assess changes in quality of life and nutrition through various indicators over the treatment period. It is a multicenter, prospective, open-label, randomized controlled trial designed to provide insights into the benefits of postbiotics for this vulnerable population.
Why it matters
Potential benefit: If successful, this study could significantly improve the quality of life and nutritional status of elderly patients on hemodialysis.
How similar studies have gone: While the specific use of postbiotics in this context is novel, similar studies have shown promising results in improving health outcomes in patients with chronic conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Investigators must maintain a screening log of all potential study candidates that includes limited information about the potential candidate, date, and outcome of the screening process (e.g. enrolled into study, reason for ineligibility, or refused to participate). After signing an informed consent form, potential patients must meet all of the criteria: 1. Age ≥65 years. 2. Receiving maintenance hemodialysis therapy for at least 6 months. Exclusion Criteria: The following exclusion criteria must NOT be present for each subject: 1. Subjects with medical history that might affect oral feeding (e.g. intestinal obstruction, gastrointestinal bleeding, acute pancreatitis and accidental inhalation) within the last 1 month prior to screening. 2. Subjects with medical history that might affect gastrointestinal functions (e.g. inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), short bowel syndrome (SBS), et al.). 3. Subjects who cannot communicate and collaborate normally.
Where it's running
-
Peking UFH
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: Yuqing Chen
- Email: cyq@bjmu.edu.cn
- Phone: 86-010-82572254
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Intradiay dialysis exercise to improve posture in adults with end-stage kidney disease
This study tests whether a 12-week supervised exercise program done during dialysis can improve posture in adults on maintenance hemodialysis.
-
Progressive muscle relaxation to ease depression and fatigue during hemodialysis
This trial will try whether guided progressive muscle relaxation can reduce depression and fatigue in people receiving hemodialysis.
-
Changing magnesium and acid type in dialysis fluid to reduce clotting and immune activation
This project tests whether changing the magnesium level and acid type in dialysis fluid can reduce immune-driven clotting and inflammation in people on maintenance hemodialysis.
-
Vericiguat for people with heart failure and chronic kidney disease on dialysis
This study will try vericiguat in adults with chronic kidney disease who are on dialysis and have heart failure with reduced ejection fraction to see how it works and how well patients tolerate it.
-
Examining Iron Metabolism in Hemodialysis Patients
This study looks at how iron works in the bodies of people on hemodialysis to see how it relates to their overall health and other important minerals.
-
Using electrical stimulation to improve balance and mobility in hemodialysis patients with diabetes
This study is testing whether a wearable electrical device can help improve balance and mobility for people with diabetes who are on hemodialysis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.